TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.

Details

Ressource 1Download: 21570352_Postprint.pdf (1504.67 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_EC7CF00354A2
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Journal
Lancet Oncology
Author(s)
Bonnefoi H., Piccart M., Bogaerts J., Mauriac L., Fumoleau P., Brain E., Petit T., Rouanet P., Jassem J., Blot E., Zaman K., Cufer T., Lortholary A., Lidbrink E., André S., Litière S., Lago L.D., Becette V., Cameron D.A., Bergh J., Iggo R.
Working group(s)
EORTC 10994/BIG 1-00 Study Investigators
ISSN
1474-5488 (Electronic)
ISSN-L
1470-2045
Publication state
Published
Issued date
2011
Volume
12
Number
6
Pages
527-539
Language
english
Notes
Publication types: Clinical Trial, Phase III ; Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Keywords
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Breast Neoplasms/chemistry, Breast Neoplasms/drug therapy, Female, Humans, Middle Aged, Mutation, Neoadjuvant Therapy, Receptor, erbB-2/analysis, Receptors, Estrogen/analysis, Taxoids/administration & dosage, Taxoids/therapeutic use, Tumor Suppressor Protein p53/genetics, Tumor Suppressor Protein p53/physiology
URN
urn:nbn:ch:serval-BIB_EC7CF00354A27
OAI-PMH
oai:serval.unil.ch:BIB_EC7CF00354A2
DOI
10.1016/S1470-2045(11)70094-8
Pubmed
21570352
Web of science
000291842400016
Open Access
Yes
Create date
25/10/2011 8:25
Last modification date
20/08/2019 16:14
Usage data